Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Person › Details

David M. Mott (New Enterprise Associates (NEA))

Mott, David M. (New Enterprise Associates 200809 General Partner before MedImmune 200604–200806 CEO)

 

Organisations Organisation New Enterprise Associates (NEA)
  Former/major organisation MedImmune Inc. (Nasdaq: MEDI)
  Today MedImmune (biologics division of AstraZeneca)
  Group AstraZeneca (Group)
Products Product venture capital
  Product 2 biopharmaceutical
     

   
Record changed: 2019-08-04

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80


More documents for David M. Mott


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top